This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Mandana Namdar: Innovator in Cancer Treatment
Introduction
Mandana Namdar is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer research, particularly through her innovative approaches to treatment.
Latest Patents
Namdar holds a patent for HDAC 6 inhibitor-based methods for treating cancer. This invention provides methods for treating a subject afflicted with cancer, comprising concurrently administering an HDAC 6-selective inhibitor and a suitable cytotoxic agent such as SAHA, doxorubicin, or etoposide. Additionally, her invention includes methods for inducing the death of a transformed cell, such as a cancer cell, by concurrently contacting the cell with an HDAC 6-selective inhibitor and a suitable cytotoxic agent.
Career Highlights
Mandana Namdar is affiliated with the Sloan-Kettering Institute for Cancer Research, where she continues to advance her research and innovations in cancer treatment. Her work is pivotal in developing new therapeutic strategies that could improve patient outcomes.
Collaborations
Some of her notable coworkers include Paul A. Marks and Weisheng Xu, who contribute to the collaborative efforts in cancer research at the institute.
Conclusion
Mandana Namdar's innovative work in cancer treatment exemplifies the impact of research and invention in the medical field. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile